Clinical Trials Browser

Phase NA × Trastuzumab × Gastrointestinal × Clear all

NCT04281576 2024-11-14

Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma

Phase NA Completed

Gastrointestinal

Stomach Neoplasms

NCT03843749 2019-02-18

Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar.

Phase NA Unknown

Gastrointestinal

Colorectal Neoplasms